Skip to main content
. 2022 Jun 3;13:3123. doi: 10.1038/s41467-022-30861-z

Table 1.

Individual survival data of the hTERT peptide vaccine trial.

Patient Observation Period (years) CTL response CMV response Outcome
A1 5.2 + dead
A2 10.9 + + alive
A3 6.1 + dead
A4 10.4 + alive
A5 7.3 + dead
A6 10.5 + alive
A7 3.6 dead
A8 9.8 + alive
A9 4.5 dead
A10 3.0 dead
A11 0.8 dead
A12 2.9 dead
A13 3.0 dead
A14 7.8 + dead
Fisher’s exact P value >0.9999